Study: NCT03361956

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-56136379
Description: Participants will receive JNJ-56136379 tablet orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-56136379
Description: Participants will receive JNJ-56136379 tablet orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-56136379
Description: Participants will receive JNJ-56136379 tablet orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-56136379
Description: Participants will receive JNJ-56136379 tablet orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-56136379
Description: Participants will receive JNJ-56136379 tablet orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-56136379
Description: Participants will receive JNJ-56136379 tablet orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive matching placebo tablet orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive matching placebo tablet orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive matching placebo tablet orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive matching placebo tablet orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NA (ETV or TDF)
Description: Participants will receive NA (ETV or TDF) tablet orally as per approved label.